As the pandemic still rages in many countries and bruised countries like the UK take their first steps to kick start the economy will we return to our normal reliance on the global supply chains? We business and the public look to buy products made closer to home, Buy British? Will the business be able to sustain the higher costs? The fragility of the global supply chain became very apparent as first China then India closed down and the pharma supply chain to most of the world was under threat. Britain has a pandemic and Brexit to deal with in the coming months and many of the companies who wish to supply the UK will be watching closely to see what the MHRA will announce in the coming months. The NHS keeps the costs of medicines in the UK down and therefore this is another consideration for suppliers is there enough margin, is it worth the effort should they focus on bigger markets. Over the past few months, the key UK suppliers have collaborated to ensure the efficient use of resources and to protect the fragile supply chain to maintain the supply of key medicines, sharing intelligence to ensure active substances and excipients were used wisely to prevent out of stock situations. It is unlikely that the UK will run a buy British for pharmaceuticals as the NHS probably cannot afford to.
Buy British, will the public shun Chinese products?
by Jackie (née Heneghan) Peck | Jun 25, 2020 | Blog
Recent Posts
Testimonials
“This is the pharma cogent course “ronseal” excellent through the whole process”
Cogent Responsible Person, December 2020
“Very informative and very helpful. Brian was very professional and very patient with our numerous questions. Thank you.” Catherine Hodges – Course Rating 10/10
GDP & RP
“As participants, we were all able to interact, engage and shared a worth of knowledge and opinion from various industries. This made the sessions very informative, valuable and interesting.”
Cogent, Dec 2020
“RP training at PCL helped me to understand current MHRA guideline to fill my knowledge gap. The trainers are really experienced and updated with current pharmaceuticals wholesale regulations.” – January 2021
Cogent Gold Standard Responsible Person Training
“Index the presentation to be able to reference quicker – detailed key acronyms. Good course, very enlightening for understanding and questioning current processes within our company.” Craig Buzzard – Course Rating 9/10
GDP & RP Training
Very good overview of GDP requirements which has given me a much better understanding of client requirements for the services and products we supply. Isatec on site training – Bill Castle
GDP/RP Training
I attended one of the first virtual GDP Responsible Person Cogent “Gold Standard” training sessions due to the Covid-19 social distancing requirements. regardless of the circumstances the training was well organised and delivered to the required standard. This is why I recommended my associates to utilise PCL. Thank you Ryan, Sally, Adel and Jackie. Goncalo Sousa – Quality Head UK at the Janssen Pharmaceutical Companies of Johnson & Johnson 05/05/2020
Cogent Gold Standard GDP Online Training
“Very Informative. Great handouts to take away. Thanks” Megan – Course Rating 10/10
Export Training
” There was a lot to take in, the course was very detailed” John Sie Han Woag – Course Rating 9/10
Export Training
Very good informative trainer, excellent delivery on a rather dull topic. Kept our interest well which helped with learning. Jackie answered every questions I had. Thank you
Ross Johnston from Survitec